The researchers maintained regular contact with participants through weekly phone calls and monthly meetings, providing support and monitoring compliance
Russia: Approved prescription medication since 2009 Marketed as Selanc nasal spray (0.15% solution) Indicated for generalized anxiety disorder and neurasthenic conditions Available through pharmacies with a physician's prescription United States: Not FDA-approved for any indication Not classified as a controlled substance (not DEA-scheduled) In September 2024, Selank acetate (TP-7) was removed from the FDA's Category 2 bulk drug substances list because the nominators withdrew their nominations, not because the FDA cleared it for safety Status for compounding use under Section 503A/503B of the Federal Food, Drug, and Cosmetic Act remains under review pending Pharmacy Compounding Advisory Committee evaluation Cannot legally be marketed as a drug, food, or dietary supplement with therapeutic claims Available as a research chemical from unregulated suppliers European Union, United Kingdom, Canada, Australia: Not approved by the EMA, MHRA, Health Canada, or TGA Exists in a regulatory gray area as a research compound Importation for personal use varies by jurisdiction and is subject to customs enforcement The regulatory asymmetry between Russia (where Selank is an established pharmaceutical) and Western countries (where it remains unapproved) reflects differences in clinical trial standards and regulatory pathways rather than any specific safety finding that has prevented approval
doi: 10.1016/S0269-7491(99)00238-9 13 ChenG.WangJ.HeG.LiS.LiX.TaoX.et al
Alternatively, the AFB 1 -epoxide can hydrolyse spontaneously to AFB 1 -dihydrodiol
If youve been frustrated with hidden costs or vague answers from other telehealth providers, this kind of clarity might be a good fit, even if its not the best at updating the website right away when things change
